In vitro Activities of Nisin Alone or in Combination with Vancomycin and Ciprofloxacin against Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains

被引:53
|
作者
Dosler, Sibel [1 ]
Gerceker, A. Alev [1 ]
机构
[1] Istanbul Univ, Fac Pharm, Dept Pharmaceut Microbiol, TR-34116 Istanbul, Turkey
关键词
Nisin; Staphylococcus aureus; Time-kill curve; Ciprofloxacin; Vancomycin; PEPTIDES; LANTIBIOTICS; BACTERIA;
D O I
10.1159/000335598
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We investigated the in vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant (MRSA) and -susceptible Staphylococcus aureus (MSSA) strains. Methods: The minimum inhibitory concentrations were determined by microbroth dilution technique. Antibiotic combinations were assessed using the checkerboard technique. The time-kill curve method was used for determining the bactericidal activity of nisin alone and in combination. Results: For both MSSA and MRSA strains, the minimum inhibitory concentrations of nisin ranged between 4 and 16 mg/l. With a fractional inhibitory concentration of >= 0.5 as borderline, synergistic interactions were seen in three of five isolates with nisin-ciprofloxacin compared to two of five isolates with nisin-vancomycin combinations against both MSSA and MRSA. No antagonism was observed. The results of time-kill curve analysis demonstrated concentration-dependent rapid bactericidal activity of nisin and synergism almost in all strains when nisin was used in combination with ciprofloxacin, and early synergistic interactions in some of the strains when it was used in combination with vancomycin. Conclusion: Nisin seems to be a good candidate for further investigations in the treatment of Gram-positive bacteria, alone or in combination with antibiotics. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:511 / 516
页数:6
相关论文
共 50 条
  • [21] Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains
    Pujol, M
    Pena, C
    Pallares, R
    Ariza, J
    Ayats, J
    Dominguez, MA
    Gudiol, F
    AMERICAN JOURNAL OF MEDICINE, 1996, 100 (05): : 509 - 516
  • [22] INVITRO ACTIVITY OF CIPROFLOXACIN AGAINST METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCI
    GAHRNHANSEN, B
    SOGAARD, P
    ARPI, M
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (05) : 581 - 584
  • [23] In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis
    Lozniewski, A
    Lion, C
    Mory, F
    Weber, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (01) : 83 - 86
  • [24] In vitro activity of gallium maltolate against methicillin-susceptible and methicillin-resistant Staphylococcus aureus and S-epidermidis
    Trampuz, A.
    Baldoni, D.
    Steinhuber, A.
    Zimmerli, W.
    SWISS MEDICAL WEEKLY, 2009, 139 (9-10) : 38S - 38S
  • [25] Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
    Panesso, Diana
    Planet, Paul J.
    Diaz, Lorena
    Hugonnet, Jean-Emmanuel
    Tran, Truc T.
    Narechania, Apurva
    Munita, Jose M.
    Rincon, Sandra
    Carvajal, Lina P.
    Reyes, Jinnethe
    Londono, Alejandra
    Smith, Hannah
    Sebra, Robert
    Deikus, Gintaras
    Weinstock, George M.
    Murray, Barbara E.
    Rossi, Flavia
    Arthur, Michel
    Arias, Cesar A.
    EMERGING INFECTIOUS DISEASES, 2015, 21 (10) : 1844 - 1848
  • [26] Are methicillin-susceptible Staphylococcus aureus carriers protected from methicillin-resistant Staphylococcus aureus infections?
    Regev-Yochay, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (01) : 4 - 5
  • [27] In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources
    Matthias Napp
    Georg Daeschlein
    Sebastian von Podewils
    Peter Hinz
    Steffen Emmert
    Hermann Haase
    Romy Spitzmueller
    Denis Gümbel
    Richard Kasch
    Michael Jünger
    Infection, 2016, 44 : 531 - 537
  • [28] Prior Vancomycin Use Is a Risk Factor for Reduced Vancomycin Susceptibility in Methicillin-Susceptible but Not Methicillin-Resistant Staphylococcus aureus Bacteremia
    Mascitti, Kara B.
    Edelstein, Paul H.
    Fishman, Neil O.
    Morales, Knashawn H.
    Baltus, Andrew J.
    Lautenbach, Ebbing
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (02): : 160 - 166
  • [29] In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources
    Napp, Matthias
    Daeschlein, Georg
    von Podewils, Sebastian
    Hinz, Peter
    Emmert, Steffen
    Haase, Hermann
    Spitzmueller, Romy
    Guembel, Denis
    Kasch, Richard
    Juenger, Michael
    INFECTION, 2016, 44 (04) : 531 - 537
  • [30] In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains
    Kaya, Onur
    Akcam, Fusun Zeynep
    Temel, Esra Nurlu
    MICROBIAL DRUG RESISTANCE, 2008, 14 (02) : 151 - 153